Second Line Capital »

Abbvie shares owned by Second Line Capital

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by Second Line Capital from 13F filings

Historical chart of Second Line Capital investment in Abbvie

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by Second Line Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by Second Line Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $338k 1.5k 231.54
2025-06-30 $330k 1.8k 185.66
2025-03-31 $349k 1.7k 209.47
2024-12-31 $207k 1.2k 177.69
2024-09-30 $379k 1.9k 197.50

More positions owned by Second Line Capital

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Etf Ser Solutions Aptus Drawdown (ADME)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Etf Ser Solutions Aptus Enhanced (JUCY)
Applovin Corp Com Cl A (APP)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Etf Ser Solutions Aptus Large Cap (DUBS)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded First Tr Enh New (FTSM)

View all positions for Second Line Capital

Top funds holding Abbvie

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Morgan Stanley
Geode Capital Management
Charles Schwab Investment Management
Capital Research Global Investors
Northern Trust
FMR
Franklin Resources
Goldman Sachs Group
UBS Group
Ubs Global Asset Management Americas
Bank of New York Mellon

View all funds holding Abbvie